Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pathology and Laboratory Medicine, |
RCV001357219 | SCV001552615 | pathogenic | Carcinoma of colon | no assertion criteria provided | clinical testing | The c.1039-?_1558+?del variant is predicted to result in a deletion of exon 12 and 13. The precise breakpoint of this deletion was not deteremined and so the consequence of this alteration cannot be predicted with certainty. Exon skipping is possible or the creation of an alternatively spliced product that leads to a premature stop codon, a truncated or absent protein product and loss of function, are possibilities. This variant in the MLH1 gene is of the type that is expected to cause the disorder and is an established mechanism of mutation in hereditary colon cancer patients. In summary, based on the above information, this variant is classified as pathogenic. |